ESSA Pharma Inc. announced a capital distribution of $80 million to shareholders, amounting to approximately $1.69 per share, scheduled for payment on August 22, 2025. The ex-dividend date is set for August 25, 2025, following the winding-up of the company’s business due to its transaction with XenoTherapeutics, Inc.